To evaluate the Safety and efficacy of Unani formulations in the treatment of Dysentery

Clinical Validation of Unani Pharmacopoeal formulation Tiryaq-e-Pachish in Zaheer (Dysentery)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/12/004262

Enrollment

170

Registered

2013-12-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A060- Acute amebic dysentery Health Condition 2: null- DYSENTRY

Interventions

Intervention1: Tiryaaq e Pechish: 5gm BD orally for one week Duration of Therapy is one week Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: • Age-20-60 • Increased frequency of motion • Tenesmus • Sense of incomplete evacuation • Frequent constipation followed by diarrhoea • Loose stools with or without mucous • Associated symptoms like Nausea /Flatulence /Vomiting

Exclusion criteria

Exclusion criteria: 1 Patients with severe loose motion more than 8 in a day 2 Patients with blood in stool 3 Cholera/Ulcerative colitis 4 High grade fever (more than 101 ÂºC) 5 Patient having illnesses requiring long term treatment especially DM, CRF,HT

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptomsTimepoint: 1 WEEK	—

Secondary

Measure	Time frame
Hematological and biochemical assessments for safetyTimepoint: 1 WEEK	—

Countries

India

Contacts

Public ContactDr Abdul Hannan

Central Council for Research in Unani Medicine (CCRUM),

ccrum605@gmail.com011-28521981

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026